ExacTrac 5.x Patient Positioning System 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Brainlab AG 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2013-04-09
  • 사례 출판 날짜
    2013-04-09
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: brainlab exactrac 5.X patient positioning system medical device manufacturer, brainlab ag, has issued a field safety notice concerning exactrac 5.X patient positioning systemversions 5.0 and 5.5 (v. 5.0, 5.0.1, 5.0.2 and v. 5.5, 5.5.1, 5.5.2). there is an anomaly detected in exactrac 5.X when used in combination with anon-brainlab radiation treatment planning system (tps). this anomaly can mislead the user whenselecting a treatment plan / isocenter (radiation treatment target) in exactrac for patient positioning atthe linear accelerator (linac). when using a specific plan update workflow in combination with a non-brainlab tps, there is a possibility in exactrac 5.X to generate an unintended blend of two initially separate plans of the same patient. if the anomaly occurs in exactrac 5.X when using a specific plan update workflow in combination with a non-brainlab tps, such a display of inconsistent positioning information might mislead the user when selecting a treatment plan / isocenter in exactrac for patient positioning. if not detected by the user, this might result in a patient and treatment target position at the linear accelerator (linac) that is different than intended. as a consequence the treatment dose might be delivered to a region different from the intended targetregion. if the deviation would exceed clinically acceptable limits,this could result in ineffectivetreatment, serious patient injury or even death of the patient. the manufacturer will send the field safety notice to all affected users and reminds users to follow the steps as mentioned in the section “user corrective action”. brainlab also advises users to continue to follow the instructions and warnings as described in the user guide. especially relevant are the warnings in the exactrac clinical user guide for reviewing isocenter information regarding plausibility and correctness, before patient positioning and treatment. besides, brainlab will provide a software update to affected customers to solve this issue. according to the local supplier, the affected products were distributed in hong kong. if you are in possession of the affected product, please contact your supplier for necessary actions. posted on 9 april 2013.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Brainlab ExacTrac 5.x Patient Positioning System
  • Manufacturer

Manufacturer